186 results
6-K
EX-99.1
REPCF
Replicel Life Sciences Inc.
30 Nov 23
Condensed Consolidated Interim Financial Statements
1:05pm
course of business for which the ultimate tax determination is uncertain. The Company recognizes liabilities and contingencies for anticipated tax audit
6-K
EX-99.2
REPCF
Replicel Life Sciences Inc.
30 Nov 23
Condensed Consolidated Interim Financial Statements
1:05pm
and authorized for issue by the Company's Audit Committee on behalf of our Board of Directors on November 28, 2023.
Cautionary Statement Regarding … for anticipated tax audit issues based on the Company's current understanding of the tax law. For matters where it is probable that an adjustment will be made
6-K
EX-99.1
REPCF
Replicel Life Sciences Inc.
24 Oct 23
Condensed Consolidated Interim Financial Statements
11:10am
liabilities and contingencies for anticipated tax audit issues based on the Company's current understanding of the tax law. For matters where
6-K
EX-99.2
REPCF
Replicel Life Sciences Inc.
24 Oct 23
Condensed Consolidated Interim Financial Statements
11:10am
for issue by the Company's Audit Committee on behalf of our Board of Directors on October 23, 2023.
Cautionary Statement Regarding Forward-Looking … and contingencies for anticipated tax audit issues based on the Company's current understanding of the tax law. For matters where it is probable
6-K
EX-99.2
REPCF
Replicel Life Sciences Inc.
30 Aug 23
Notice of Annual General and Special Meeting of Shareholders
5:15pm
of British Columbia's Tech Equity Investment Committee, a director and Chairman of the Audit Committee of GLG Lifetech Corporation, as well as Advantage … furnished by the respective nominees as at January 20, 2023.
(3) Member of the Audit Committee of the Company.
(4) Member of the Nominating, Compensation
6-K
EX-99.1
nhzstidzq p8l8qf9f
9 Aug 23
Statement of Executive Compensation
7:41pm
6-K
EX-99.2
f7yh3k6kfy 2rgr
30 May 23
Condensed Consolidated Interim Financial Statements
5:40pm
6-K
EX-99.1
abmhbg
30 May 23
Condensed Consolidated Interim Financial Statements
5:40pm
6-K
EX-99.1
idj68p4pz
8 Dec 22
Current report (foreign)
5:46pm
6-K
EX-99.2
futkqccsxb wjeqtu6
29 Nov 22
Condensed Consolidated Interim Financial Statements
6:44pm
6-K
EX-99.1
e8zkl0pe ycf
29 Nov 22
Condensed Consolidated Interim Financial Statements
6:44pm
20-F/A
uziguo55wvc3vknsy
12 Sep 22
Annual report (foreign) (amended)
6:17pm
20-F/A
EX-12.2
qjdv99
12 Sep 22
Annual report (foreign) (amended)
6:17pm
20-F/A
EX-12.1
n7wi2sj7wku04bhe6
12 Sep 22
Annual report (foreign) (amended)
6:17pm
6-K
EX-99.2
36utg
6 Sep 22
Condensed Consolidated Interim Financial Statements
12:42pm
6-K
EX-99.1
s4jluzx8i
6 Sep 22
Condensed Consolidated Interim Financial Statements
12:42pm
UPLOAD
bhnchxjrg4d5u
23 Aug 22
Letter from SEC
12:00am